Patents by Inventor Mehar S Manku

Mehar S Manku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6177470
    Abstract: Optimum conditions for prostaglandin synthesis are provided by internally administering an ascorbic-6-acid ester of gamma-linolenic acid or an ascorbic-6-acid ester of dihomo-gamma-linolenic acid.
    Type: Grant
    Filed: March 2, 1998
    Date of Patent: January 23, 2001
    Assignee: Scotia Holdings PLC
    Inventors: David F Horrobin, Philip Knowles, Mehar S Manku
  • Patent number: 5847000
    Abstract: Ascorbyl-GLA or Ascorbyl-DGLA in medicaments for treatment of asthma and other disorders.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: December 8, 1998
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, Philip Knowles, Mehar S Manku
  • Patent number: 5635189
    Abstract: A natural vitamin E preparation, i.e. vitamin E extracted from natural sources, comprising one or more of the alpha-, beta-, gamma- and delta-tocopherol forms, either as the tocopherol itself, or as a derivative, such as the acetate, in which the total concentration of Wendt PAHs is less than 100 ppb.
    Type: Grant
    Filed: August 29, 1994
    Date of Patent: June 3, 1997
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, Mehar S. Manku
  • Patent number: 5466841
    Abstract: A phospholipid comprising two different unsaturated fatty acids, the fatty acids being selected from the twelve n-6 and n-3 essential fatty acids, oleic acid, parinaric acid and combinic acid.
    Type: Grant
    Filed: January 27, 1994
    Date of Patent: November 14, 1995
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, Austin McMordie, Mehar S. Manku
  • Patent number: 4965075
    Abstract: Methods of influencing the 1-series/2-series PG balance in the body by administering a composition containing .gamma.-linolenic acid and/or dihomo-.gamma.-linolenic acid and assimilable copper compounds optionally with a diluent or carrier, the acids being as such or as derivatives convertible in the body thereto. The amounts of the acids or derivatives are 0.2 to 10 g (calculated as .gamma.-linolenic acid) and of copper compounds are 0.1 to 100 mg (calculated as copper).
    Type: Grant
    Filed: November 21, 1988
    Date of Patent: October 23, 1990
    Assignee: Efamol Limited
    Inventors: David F. Horrobin, Stephen C. Cunnane, Mehar S. Manku
  • Patent number: 4666701
    Abstract: Gamma-linolenic acid or dihomo-gamma-linolenic acid for use in the reduction or prevention of gastro-intestinal bleeding and other side effects shown by NSAIDs when administered on a continuing basis, including use in allowing said administration to be replaced by administration of said acid alone in arthritis and other conditions without exacerbation of symptoms.
    Type: Grant
    Filed: March 13, 1986
    Date of Patent: May 19, 1987
    Assignee: Efamol Limited
    Inventors: David F. Horrobin, Mehar S. Manku, Yung S. Huang